Generate Biomedicines, Inc. (GENB)

17.38 +0.24 (+1.40%) USD  |  NASDAQ  |  Sep 21, 16:00
17.52 +0.14 (+0.81%) Pre-Market: 08:51
More

Generate Biomedicines CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Intellia Therapeutics, Inc. Upgrade
Prime Medicine, Inc. Upgrade
Moderna, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade